Palatin Technologies Inc
PTN Nasdaq Pharmaceutical Preparations Financials FY2017βFY2026
What Palatin Technologies Inc does
No business description yet.
- Legal name
- PALATIN TECHNOLOGIES INC
- Fiscal year ends
- June 30, 2026
- Latest annual report
- 10-K Β· Sep 28, 2026
- Accession Β· CIK
- 0001493152-26-044572
0000911216
Revenue and margins
Palatin Technologies Inc had $8.8M of revenue in fiscal 2026.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$13.6M in fiscal 2026, β153.8% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Palatin Technologies Inc returned β to shareholders in fiscal 2026. The diluted share count rose 425.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably Palatin Technologies Inc can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $29.9M | $14.0M | $9.5M | $2.6M | $7.5M |
| Interest coverage | β1,231.9x | β1,622.9x | β1,315.6x | β1,164.0x | β1,293.8x |
| Current ratio | 2.1x | 1.1x | 1.0x | 0.4x | 4.6x |
| Quick ratio | 2.1x | 1.0x | 1.0x | 0.4x | 4.6x |
| Total assets | $36.1M | $17.9M | $10.7M | $3.3M | $8.5M |
| Total liabilities | $19.8M | $19.7M | $10.9M | $8.0M | $1.8M |
| Shareholders' equity | $16.3M | β$2.0M | β$0.1M | β$4.8M | $6.7M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 7 / 8 | 3 / 8 | 2 / 7 | 1 / 7 | β / 6 | 2 / 7 | 2 / 7 | 0 / 7 | 3 / 7 |
| Accruals ratio | 20.8% | 48.0% | 80.1% | β67.2% | β44.0% | β12.1% | 19.4% | 12.0% | 57.1% | 87.4% |
| Altman Z'' | β17.30 | β16.26 | 24.59 | 9.33 | β12.02 | β37.69 | β86.71 | β148.08 | β504.85 | β176.87 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $67.1M | $67.1M | $60.3M | $0.1M | β$0.2M | $1.5M | $4.9M | $4.5M | $0.0M | $8.8M |
| Gross profit | β | β | β | $0.1M | β$0.3M | $1.3M | $4.4M | $4.4M | β | β |
| Research and development | $32.6M | $32.6M | $14.9M | $14.0M | $12.9M | $21.3M | $22.6M | $22.4M | $14.9M | $12.4M |
| Operating income | $25.9M | $25.9M | $35.7M | β$23.6M | β$33.4M | β$36.6M | β$32.5M | β$22.5M | β$17.5M | β$8.7M |
| Interest expense | $1.5M | $1.5M | $0.4M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Pretax income | $24.8M | $24.8M | $35.8M | β$22.4M | β | β$36.2M | β$32.2M | β | β | β |
| Income tax | $0.1M | $0.1M | $0.0M | $0.0M | β | $0.0M | β$4.7M | β$29.7M | β$17.3M | β$8.4M |
| Net income | $24.7M | $24.7M | $35.8M | β$22.4M | β$33.6M | β$36.2M | β$24.0M | β$29.7M | β$17.3M | β$8.4M |
| Diluted EPS | $0.12 | $0.12 | $0.16 | β$0.10 | β$0.14 | β | β | β$101.16 | β$32.15 | β$2.96 |
| Diluted shares | 0.21B | 0.21B | 0.22B | 0.23B | 0.24B | β | β | 0.00B | 0.00B | 0.00B |
| Cash flow | ||||||||||
| Cash from operations | $12.9M | $1.7M | β$21.8M | $41.3M | β$0.1M | β$29.9M | β$29.3M | β$31.5M | β$21.3M | β$13.5M |
| Capital expenditure | $0.1M | $0.0M | $0.0M | $0.1M | $0.0M | $0.3M | $0.4M | $0.0M | $0.0M | $0.1M |
| Free cash flow | $12.7M | $1.7M | β$21.8M | $41.3M | β$0.1M | β$30.2M | β$29.7M | β$31.5M | β$21.3M | β$13.6M |
| Depreciation and amortization | $0.0M | $0.1M | $0.1M | $0.1M | $0.1M | $0.1M | $0.3M | $0.3M | $0.3M | $0.1M |
| Stock-based compensation | $1.8M | $3.5M | $3.5M | $3.1M | $3.2M | $2.5M | $1.7M | $1.9M | $1.4M | $1.3M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $40.2M | $38.0M | $43.5M | $82.9M | $60.1M | $29.9M | $14.0M | $9.5M | $2.6M | $7.5M |
| Total debt | $6.3M | $0.3M | $0.3M | β | β | β | β | β | β | β |
| Finance lease liabilities | β | β | β | β | $0.0M | β | $0.2M | β | β | β |
| Current assets | $56.6M | $38.5M | $104M | $83.6M | $65.9M | $34.6M | $16.3M | $9.8M | $2.9M | $8.2M |
| Current liabilities | $55.0M | $10.8M | $4.2M | $3.9M | $10.5M | $16.3M | $15.1M | $9.7M | $8.0M | $1.8M |
| Inventory | β | β | β | $0.0M | $1.2M | $0.9M | $0.5M | $0.0M | β | β |
| Property and equipment, net | $0.2M | $0.2M | $0.1M | $0.1M | $0.1M | $0.5M | $0.7M | $0.4M | $0.1M | $0.1M |
| Total assets | $56.8M | $39.0M | $105M | $85.1M | $67.3M | $36.1M | $17.9M | $10.7M | $3.3M | $8.5M |
| Total liabilities | $62.0M | $12.1M | $4.2M | $4.9M | $17.6M | $19.8M | $19.7M | $10.9M | $8.0M | $1.8M |
| Preferred stock | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | β | β | β |
| Shareholders' equity | β$5.2M | $27.0M | $101M | $80.2M | $49.7M | $16.3M | β$2.0M | β$0.1M | β$4.8M | $6.7M |
| Margins | ||||||||||
| Gross margin | β | β | β | 100.0% | 178.4% | 85.2% | 91.4% | 97.8% | β | β |
| Operating margin | 38.6% | 38.6% | 59.3% | β20,005.8% | 17,701.0% | β2,491.5% | β668.7% | β501.0% | β | β98.2% |
| EBITDA margin | 38.7% | 38.7% | 59.4% | β19,951.4% | 17,673.9% | β2,482.9% | β662.8% | β493.5% | β | β97.5% |
| Net margin | 36.8% | 36.8% | 59.3% | β19,005.1% | 17,813.6% | β2,465.0% | β495.2% | β662.3% | β | β94.9% |
| FCF margin | 19.0% | 2.5% | β36.2% | 34,969.1% | 52.7% | β2,055.4% | β612.0% | β701.6% | β | β153.8% |
| Returns | ||||||||||
| Return on capital | β | β | 62.3% | β | β | β | β | β | β | β |
| Return on capital employed | 1,385.7% | 91.8% | 35.5% | β29.1% | β58.8% | β184.7% | β1,156.1% | β2,074.1% | 368.1% | β128.4% |
| Return on equity | β | 226.6% | 56.1% | β24.8% | β51.8% | β109.8% | β336.5% | β | β | β877.5% |
| Return on assets | 43.5% | 51.5% | 49.8% | β23.6% | β44.1% | β70.0% | β89.0% | β207.4% | β247.1% | β142.1% |
| Return on tangible equity | β | 91.6% | 35.6% | β28.0% | β67.7% | β222.5% | β | β | β | β125.3% |
| Growth | ||||||||||
| Revenue growth | β | 0.0% | β10.2% | β99.8% | β259.8% | β | 230.5% | β7.5% | β100.0% | β |
| Net income growth | β | 0.0% | 44.8% | β162.7% | β | β | β | β | β | β |
| EPS growth | β | 0.0% | 33.3% | β162.5% | β | β | β | β | β | β |
| FCF growth | β | β86.8% | β1,398.3% | β | β100.2% | β | β | β | β | β |
| Share count change | β | 0.0% | 4.9% | 8.1% | 0.8% | β | β | β | 83.1% | 425.2% |
| Financial health | ||||||||||
| Net debt / EBITDA | β1.3x | β1.4x | β1.2x | β | β | β | β | β | β | β |
| Debt / equity | β | 0.0x | 0.0x | β | β | β | β | β | β | β |
| Interest coverage | 17.9x | 17.9x | 85.6x | β1,174.5x | β1,426.7x | β1,231.9x | β1,622.9x | β1,315.6x | β1,164.0x | β1,293.8x |
| Current ratio | 1.0x | 3.6x | 24.9x | 21.3x | 6.3x | 2.1x | 1.1x | 1.0x | 0.4x | 4.6x |
| Quick ratio | 1.0x | 3.6x | 24.9x | 21.3x | 6.2x | 2.1x | 1.0x | 1.0x | 0.4x | 4.6x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.2% | 0.0% | 0.1% | 53.3% | β3.0% | 17.8% | 8.9% | 0.9% | β | 0.6% |
| Stock comp / revenue | 2.6% | 5.2% | 5.8% | 2,659.7% | β1,680.1% | 170.6% | 34.5% | 41.7% | β | 15.1% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 7.0 | 3.0 | 2.0 | 1.0 | β | 2.0 | 2.0 | 0.0 | 3.0 |
| Altman Z'' | β17.3 | β16.3 | 24.6 | 9.3 | β12.0 | β37.7 | β86.7 | β148.1 | β504.8 | β176.9 |
| Accruals ratio | 20.8% | 48.0% | 80.1% | β67.2% | β44.0% | β12.1% | 19.4% | 12.0% | 57.1% | 87.4% |
Source: SEC EDGAR XBRL filings (CIK 0000911216). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.